Compare APGE & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | ONDS |
|---|---|---|
| Founded | 2022 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.6B |
| IPO Year | 2023 | 2015 |
| Metric | APGE | ONDS |
|---|---|---|
| Price | $90.54 | $10.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | ★ $109.67 | $19.83 |
| AVG Volume (30 Days) | 881.1K | ★ 54.8M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $50,731,000.00 |
| Revenue This Year | N/A | $662.14 |
| Revenue Next Year | N/A | $76.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 605.31 |
| 52 Week Low | $34.34 | $0.69 |
| 52 Week High | $95.32 | $15.28 |
| Indicator | APGE | ONDS |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 60.08 |
| Support Level | $73.06 | $8.76 |
| Resistance Level | N/A | $11.87 |
| Average True Range (ATR) | 3.27 | 0.74 |
| MACD | 0.23 | 0.21 |
| Stochastic Oscillator | 64.72 | 76.98 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Ondas Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system. Geographically, the company operates in Israel, Germany, United Arab Emirates, United States, and Other Countries. It derives maximum revenue from Israel.